Radiomics for Early Detection of Recurrence in Patients Treated with Lung Stereotactic Ablative Radiotherapy (SABR)

被引：0
|
作者：
Kunkyab, T. [1 ,2 ]
Mou, B. [1 ]
Jirasek, A. [2 ]
Haston, C. [2 ]
Andrews, J. [2 ]
Thomas, S. [3 ]
Hyde, D. [1 ]
机构：
[1] BC Canc Kelowna, Kelowna, BC, Canada
[2] Univ British Columbia Okanagan, Dept Math Stat Phys & Comp Sci, Kelowna, BC, Canada
[3] BC Canc Vancouver, Vancouver, BC, Canada
来源：
MEDICAL PHYSICS | 2020年 / 47卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
BReP-SNAP-
引用
收藏
页码：E436 / E436
页数：1
相关论文
共 50 条
  • [21] Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches
    Tekatli, H.
    Spoelstra, F. O. B.
    Palacios, M.
    de Koste, J. van Sornsen
    Slotman, B. J.
    Senan, S.
    LUNG CANCER, 2018, 123 : 142 - 148
  • [22] An audit on the outcomes of patients with primary lung cancer treated with stereotactic ablative radiotherapy (SABR) at a single institute between 2013 and 2018
    Mccabe, A.
    Foweraker, K.
    Pascoe, A.
    LUNG CANCER, 2019, 127 : S76 - S76
  • [23] Stereotactic ablative body radiotherapy (SABR) for multiple lung tumours: hazardous or harmless?
    Allos, B.
    Carruthers, H.
    Harrop, V.
    Stange, D.
    Misheva, T.
    Stevenson, R.
    Watkins, S.
    Ghafoor, Q.
    LUNG CANCER, 2018, 115 : S58 - S58
  • [24] Efficacy and safety profile of Stereotactic Ablative Radiotherapy (SABR) for multiple lung primaries
    Littlejohns, A.
    Janjua, T.
    Murray, P.
    Jain, P.
    Clarke, K.
    Dickinson, P.
    Teo, M.
    Saha, A.
    Franks, K.
    Sun, F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S542 - S542
  • [25] Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience
    Ko, R. B.
    Jani, K.
    Sodji, Q.
    Merriott, D. J.
    Pickthorn, W.
    Bush, K.
    Maxim, P. G.
    Diehn, M.
    Loo, B. W., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S148 - S148
  • [26] Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments
    Tyler, Madelaine K.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2016, 17 (01): : 158 - 166
  • [27] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [28] TREATMENT OF MULTIPLE PRIMARY LUNG CANCERS (MPLC) WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR)
    Griffioen, Gwendolyn H.
    Lagerwaard, Frank
    Haasbeek, Cornelis J.
    Smit, Egbert
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S839 - S839
  • [29] Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity
    Murray, Louise
    Karakaya, Ebru
    Hinsley, Samantha
    Naisbitt, Mitchell
    Lilley, John
    Snee, Michael
    Clarke, Katy
    Musunuru, Hima B.
    Ramasamy, Satiavani
    Turner, Rob
    Franks, Kevin
    BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1058):
  • [30] A case for development of stereotactic ablative body radiotherapy (SABR) for lung cancer at Aberdeen
    Stilwell, C.
    Steven, E.
    Sharma, R. N.
    Bissett, D.
    Shrimali, R. K.
    LUNG CANCER, 2013, 79 : S58 - S59
12345